A seasoned FDA compliance and regulations expert says you can watch for these major ways health intelligence may change for ...

Lawmakers in Michigan have introduced a package of bills designed to lower costs and expand healthcare access. Senate Bill 3 ...

All you need to do is swipe down from the top-right of your iPhone and press and hold down on the new power button in the top ...

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...

Leronlimab is a monoclonal antibody investigational drug also known as PRO 140 and has been considered a potential treatment for human immunodeficiency virus (HIV). Pourhassan also sought to have the ...

The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications. The drug, suzetrigine ...

The draft also outlined strategies device companies can take to increase transparency and mitigate bias in their models. In ...

You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...

Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3% ...

Scholar Rock is asking the U.S. Food and Drug Administration (FDA) to approve apitegromab, its experimental add-on therapy designed to boost motor function in people with spinal muscular atrophy (SMA) ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

Tom Temin: So it’s OK to meet with drug industry officials? You just have to make sure that it’s known and disclosed. Ivan Troy: Yeah, it’s an issue of transparency. Tom Temin: Right. So then I guess ...